NASDAQ: TMDX - TransMedics Group, Inc.

Yield per half year: -55.81%
Dividend yield: 0.00%
Sector: Healthcare

TransMedics Group, Inc.

210.00210.00180.00180.00150.00150.00120.00120.0090.0090.0060.0060.0030.0030.00Apr '24Apr '24May '24May '24Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 57.09 -100% -34.72 -100%
P/S 10.86 33.5 -67.58%
P/BV 19.12 4.61 314.46%
P/FCF -10.98 39.66 -127.7%
Ev/Ebitda 313.28 -19.46 -1710.23%
Ev/S 11.36 22.56 -49.64%
Ev/FCF -14.29 45.47 -131.43%
E/P -0.0119 0.0172 -169%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
1/10
3.63 -14.42 -125.15% -52.03 -106.97%
ROE -18.24 9.01 -302.45%
ROA -3.54 0.0151 -23506.19%
ROIC 0 7.63 -100%
ROS -10.36 -26.5 -60.91%
ROCE 0.3535 13.75 -97.43%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
0/10
58 -3.73 -1655.74% 8.95 +548.39%
Nеt Debt/Ebitda 13.82 -3.19 -532.93%
Debt/Ratio 0.7198 0.1777 305.04%
Debt/Equity 2.01 1.57 28.18%
Debt/Net Income -20.31 0.8429 -2509.09%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5467 -100% 0 0%
Number of years of dividend growth 0 0.7368 -100%
DSI 0 0.2387 -100%
Average dividend growth 0 1.55 -100%
Average percentage for 5 years 0 0.4967 -100%
Average percentage for payments 0 43.73 -100%
Difference from average difference in sector -0.5467

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
923.65 73.67 1153.77%
Growth impulse Ebitda in 5 years -73.61 15.28 -581.74%
Growth impulse Net Income in 5 years -25.39 -33.08 -23.25%
Growth impulse FCF in 5 years 491.93 -6.99 -7137.63%
Growth impulse EPS in 5 years -67.41 -59.11 14.04%
IP Score
2.57/10

Similar companies

Illumina

Nektar Therapeutics

Henry Schein

Incyte

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription